Corpus Intelligence IC Memo — PEACE ISLAND MEDICAL CENTER 2026-04-26 13:55 UTC
IC Memo — PEACE ISLAND MEDICAL CENTER
Investment Committee Memorandum | WA | 10 beds | Grade D | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PEACE ISLAND MEDICAL CENTER

CCN 501340 | ISLAND, WA | 10 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PEACE ISLAND MEDICAL CENTER is a 10-bed community hospital in ISLAND, WA with $26.1M in net patient revenue and a -4.5% operating margin. The hospital serves a payer mix of 71.3% Medicare, 0.0% Medicaid, and 28.7% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.5% to 2.8% (+736bps).

Net Revenue HCRIS$26.1M
Current EBITDA COMPUTED$-1.2M
Operating Margin COMPUTED-4.5%
Occupancy HCRIS6.8%
Revenue / Bed COMPUTED$2.6M
Net-to-Gross HCRIS52.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

104
WA Hospitals
-10.3%
State Median Margin
12
Comparable Hospitals

WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -4.5% places it above the state median. Among 12 size-comparable peers (5-20 beds), the median margin is -9.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (5-20), prioritizing same-state peers. 12 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PEACE ISLAND MEDICAL CENTER (Target)WA10$26.1M-4.5%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
SUMMIT PACIFIC MEDICAL CENTERWA10$73.6M9.1%
NEWPORT COMMUNITY HOSPITALWA20$38.6M-4.1%
KLICKITAT VALLEY HEALTHWA16$32.3M-11.7%
FORKS COMMUNITY HOSPITALWA17$31.9M-23.5%
WILLAPA HARBOR HOSPITALWA10$26.5M-1.1%
NORTH VALLEY HOSPITALWA18$25.9M-6.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$547K+210bp18mo
Cost to Collect4.5%2.5%$521K+200bp12mo
Denial Rate Reduction12.0%6.5%$516K+198bp12mo
A/R Days Reduction5200.0%3800.0%$317K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$547K
Cost to Collect
$521K
Denial Rate Reduction
$516K
A/R Days Reduction
$317K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$-1.2M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$734K
Current Margin-4.5%
Pro Forma Margin2.8%
WC Released (1x)$1000K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.8M$11.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.8M$11.9M0.00x-100.0%
Bull Case9.0x11.0x$-1.6M$17.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.6M$18.8M0.00x-100.0%
Bear Case11.0x10.0x$-2.0M$2.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.0M$2.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 71.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 6.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 12 hospitals with 5-20 beds
  • Same-state prioritization (n=15)
  • Comp margins: P25=-23.7% / P50=-9.0% / P75=-3.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.